A patient with Crimean-Congo hemorrhagic fever serologically diagnosed by recombinant nucleoprotein-based antibody detection systems

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 3, 2003, Pages 489-491

  Tang, Qing ^a   Saijo, Masayuki ^d   Zhang, Yuzhen ^b   Asiguma, Muer ^b   Tianshu, Dong ^b   Han, Lei ^a   Shimayi, Bawudong ^c   Maeda, Akihiko ^d   Kurane, Ichiro ^d   Morikawa, Shigeru ^d  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Xinjiang Bachu Co People's Hospital   (China)

^c Bachu Co Ctr for Dis Ctrl/Prev   (China)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NUCLEOPROTEIN; RECOMBINANT PROTEIN; RIBAVIRIN; VIRUS ANTIBODY; VIRUS RNA;

ADULT; ANTIBODY DETECTION; ARTICLE; BLOOD; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; MALE; METHODOLOGY; NAIRO VIRUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY; VIRUS DETECTION; VIRUS HEMORRHAGIC FEVER; VIRUS IDENTIFICATION;

ADULT; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; NUCLEOPROTEINS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, VIRAL; SEROLOGIC TESTS;

EID: 12444264778     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.3.489-491.2003     Document Type: Article

References (9)

1. Fisher-Hoch, S. P., J. A. Khan, S. Rehman, S. Mirza, M. Khurshid, and J. B. McCormick. 1995. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 346:472-475.
2. Huggins, J. W. 1989. Prospects for treatment of viral hemorrhagic fevers with ribavirin, a broad spectrum antiviral drug. Rev. Infect. Dis. ii:S750-S761.
3. Papa, A., B. Bozovi, V. Pavlidou, E. Papadimitriou, M. Pelemis, and A. Antoniadis. 2002. Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia. Emerg. Infect. Dis. 8:852-854.
4. Rodriguez, L. L., G. O. Maupin, T. G. Ksiazek, P. E. Rollin, A. S. Khan, T. F. Schwarz, R. S. Lofts, J. F. Smith, A. M. Noor, C. J. Peters, and S. T. Nichol. 1997. Molecular investigation of a multisource outbreak of Crimean-Congo hemorrhagic fever in the United Arab Emirates. Am. J. Trop. Med. Hyg. 57:512-518.
5. Saijo, M., Q. Tang, M. Niikura, A. Maeda, T. Ikegami, C. Prehaud, I. Kurane, and S. Morikawa. 2002. An immunofluorescence technique for detection of immunoglobulin G antibodies to Crimean-Congo hemorrhagic fever virus using HeLa cells expressing recombinant nucleoprotein. J. Clin. Microbiol. 40:372-375.
6. Saijo, M., Q. Tang, M. Niikura, A. Maeda, T. Ikegami, C. Prehaud, I. Kurane, and S. Morikawa. 2002. Recombinant nucleoprotein-based enzyme-linked immunosorbent assay for detection of immunoglobulin G to Crimean-Congo hemorrhagic fever virus. J. Clin. Microbiol. 40:1587-1591.
7. Tignor, G. H., and C. A. Hanham. 1993. Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antivir. Res. 22:309-325.
8. Van de Wal, B. W., J. R. Joubert, P. J. van Eeden, and J. B. King. 1985. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part IV. Preventive and prophylactic measures. S. Afr. Med. J. 68:729-732.
9. Watts, D. M., M. A. Ussery, D. Nash, and C. J. Peters. 1989. Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Am. J. Trop. Med. Hyg. 41:581-585.